Kura Oncology, Inc. (KURA)
9.61
-0.25
(-2.54%)
USD |
NASDAQ |
Oct 23, 16:00
9.61
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Price to Book Value : 17.65 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 17.65 |
| October 22, 2026 | 18.11 |
| October 21, 2026 | 18.15 |
| October 20, 2026 | 18.33 |
| October 19, 2026 | 17.19 |
| October 16, 2026 | 16.68 |
| October 15, 2026 | 17.82 |
| October 14, 2026 | 17.65 |
| October 13, 2026 | 18.05 |
| October 12, 2026 | 19.09 |
| October 09, 2026 | 19.47 |
| October 08, 2026 | 19.32 |
| October 07, 2026 | 19.60 |
| October 06, 2026 | 19.34 |
| October 05, 2026 | 19.51 |
| October 02, 2026 | 19.56 |
| October 01, 2026 | 19.56 |
| September 30, 2026 | 19.67 |
| September 29, 2026 | 19.85 |
| September 28, 2026 | 19.49 |
| September 25, 2026 | 19.76 |
| September 24, 2026 | 19.95 |
| September 23, 2026 | 20.28 |
| September 22, 2026 | 21.54 |
| September 21, 2026 | 21.31 |
| Date | Value |
|---|---|
| September 18, 2026 | 21.54 |
| September 17, 2026 | 21.53 |
| September 16, 2026 | 20.57 |
| September 15, 2026 | 20.75 |
| September 14, 2026 | 21.23 |
| September 11, 2026 | 20.92 |
| September 10, 2026 | 21.25 |
| September 09, 2026 | 22.21 |
| September 08, 2026 | 23.00 |
| September 04, 2026 | 24.34 |
| September 03, 2026 | 24.15 |
| September 02, 2026 | 24.08 |
| September 01, 2026 | 23.68 |
| August 31, 2026 | 23.23 |
| August 28, 2026 | 23.25 |
| August 27, 2026 | 24.21 |
| August 26, 2026 | 23.99 |
| August 25, 2026 | 24.96 |
| August 24, 2026 | 22.78 |
| August 21, 2026 | 21.84 |
| August 20, 2026 | 21.51 |
| August 19, 2026 | 23.01 |
| August 18, 2026 | 22.65 |
| August 17, 2026 | 20.72 |
| August 14, 2026 | 19.95 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Inovio Pharmaceuticals, Inc. | 16.90 |
| Fortress Biotech, Inc. | 0.3917 |
| Spero Therapeutics, Inc. | 1.460 |
| Gossamer Bio, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
Price to Book Value Related Metrics
| PS Ratio | 10.99 |
| PEG Ratio | -0.0585 |
| Price | 9.61 |
| Earnings Yield | -34.99% |
| Market Cap | 854.85M |
| PEGY Ratio | -0.0585 |